Anders I. Persson

Affiliations: 
University of California, San Francisco, San Francisco, CA 
Google:
"Anders Persson"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sabelström H, Petri R, Shchors K, et al. (2019) Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma Aggressiveness. Cell Reports. 28: 2064-2079.e11
Sabelström H, Quigley D, Fenster T, et al. (2019) High density is a property of slow-cycling and treatment-resistant human glioblastoma cells. Experimental Cell Research
Guan X, Hasan MN, Begum G, et al. (2018) Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy. Cell Death & Disease. 9: 1010
Luks TL, McKnight TR, Jalbert LE, et al. (2018) Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas. Translational Oncology. 11: 941-949
Griveau A, Seano G, Shelton SJ, et al. (2018) A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment. Cancer Cell
Ilkhanizadeh S, Sabelström H, Miroshnikova YA, et al. (2018) Antisecretory Factor-mediated Inhibition of Cell Volume Dynamics Produces Anti-tumor Activity in Glioblastoma. Molecular Cancer Research : McR
Tran VM, Wade A, McKinney A, et al. (2017) Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion. Molecular Cancer Research : McR
Bull C, Cooper C, Lindahl V, et al. (2017) Exercise in Adulthood after Irradiation of the Juvenile Brain Ameliorates Long-Term Depletion of Oligodendroglial Cells. Radiation Research
Sabelstrom H, Petri R, Shchors K, et al. (2017) STEM-11. A MAPK-DRIVEN miR-124-SOX9 AXIS IS CRITICAL FOR STEM CELL MAINTENANCE, PROGRESSION, AND THERAPY-RESISTANCE IN GLIOBLASTOMA Neuro-Oncology. 19: vi228-vi228
Schmidt C, Chen S, IIkhanizadeh S, et al. (2017) EXTH-55. REPURPOSING THERAPEUTICS IN PATIENT-DERIVED GLIOMAS AND AN IDH1 MUTANT GLIOMA MODEL Neuro-Oncology. 19: vi84-vi85
See more...